SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

2026 Supreme(Bom) 1006

IN THE HIGH COURT OF JUDICATURE AT BOMBAY
Manish Pitale, Shreeram V. Shirsat, JJ.
Tridoss Laboratories Pvt. Ltd. and another - Petitioners
Versus
Union of India and others - Respondents
Writ Petition No.2789 of 2017
Decided On : 15-04-2026

Advocates Appeared:
For the Petitioner:Mr. Sharan Jagtiani, Senior Advocate with Ms. Surabhi Agrawal, Mr. Vishal Maheshwari and Ms. Kamini Pansare i/b. VM Legal
For the Respondent:Mr. A. S. Khandeparkar, Senior Advocate with Mr. D. P. Singh, Mr. Yashodeep, Deshmukh and Ms. Vaidehi Pradeep, Ms. Uma Rahi, AGP

Administrative authorities must initiate proceedings within a reasonable time. A gross delay of over a decade, which prevents a party from defending itself due to the destruction of records, violates the principles of natural justice and renders the administrative action unsustainable.

Headnote:(A) Essential Commodities Act, 1955 - Section 3 - Drugs (Price Control) Order, 1995 - Maharashtra Land Revenue Code, 1966 - Section 267 - Recovery of overcharged amount - Limitation and delay - Administrative action - Principles of natural justice - Duty to act fairly - Recording of reasons.

(B) Administrative Law - Delay in initiation of proceedings - Where a statute is silent on limitation, the authority must initiate proceedings within a reasonable period - A gross delay of over a decade in issuing demand notices for alleged overcharging, where records are no longer available, violates the principles of natural justice and renders the action unsustainable. (Paras 28, 31, 35)

(C) Administrative Law - Principles of natural justice - Requirement of fair hearing and recording of reasons - Administrative authorities must act fairly and record reasons for decisions that adversely affect legal rights - Failure to provide a hearing or record reasons for the recovery of substantial amounts as arrears of land revenue vitiates the action. (Paras 33, 34, 37, 38)

(D) Price Control - Interpretation of notifications - Inclusion of specific drug delivery systems - Where a notification specifies certain formulations, other distinct delivery systems not explicitly mentioned are not covered by implication - Subsequent inclusion of a specific formulation by amendment confirms that it was not previously covered. (Paras 43, 44)

Facts of the case:
The petitioners challenged demand notices issued by the authorities for alleged overcharging of a pharmaceutical product for a period occurring more than a decade prior. The petitioners contended that the relevant records were destroyed in accordance with standard operating procedures and that the product was not subject to price control at the material time.

Findings of Court:
The court found that the authorities failed to explain the inordinate delay in initiating proceedings, which prejudiced the petitioners' ability to defend themselves. The court further held that the authorities failed to act fairly or provide a hearing, and that the specific formulation was not covered by the price control notification at the relevant time.

Issues: Whether the demand notices issued after a decade are sustainable, whether the principles of natural justice were violated, and whether the specific drug formulation was subject to price control.

Ratio Decidendi: Administrative actions must be initiated within a reasonable time, and gross delay that prevents a party from effectively defending itself violates natural justice. Furthermore, administrative authorities must act fairly, provide a hearing, and record reasons for their decisions. Distinct drug delivery systems not explicitly included in price control notifications cannot be brought under the regime by implication.

Result: Petition allowed; impugned demand notices quashed.

ORDER : 

Manish Pitale, J.

. The petitioner No.1 is a company engaged in the business of manufacturing and marketing pharmaceutical products and petitioner No.2 is its authorized representative. They have filed this petition being aggrieved by a demand notice dated 15.02.2016 issued by respondent No.1 i.e. Union of India through Department of Pharmaceuticals as also impugned notice of demand issued to a defaulter by respondent No.3 Tahsildar under Section 267 of the Maharashtra Land Revenue Code, 1966 (for short ‘MLR Code’). The principal contention raised on behalf of the petitioners is that the petitioner No.1 is not liable to pay the amount demanded by the respondents for allegedly overcharging consumers in respect of a specific pharmaceutical formulation and that, in any case, the demand is hopelessly time-barred. The huge delay in raising the demand has resulted in depriving the petitioners from formulating their defence as the records pertaining to the relevant period were not available with the petitioners in the year 2016, when the impugned notices of demand were issued by the respondents.

2. The chronology of events leading to filing of the present writ petition would be relevant for appreciating the rival contentions. On 06.01.1995, respondent No.1 issued Drugs (Price Control) Order 1995 (DPCO 1995) by exercising power under Section 3 of the Essential Commodities Act, 1955. The First Schedule appended to DPCO 1995 specified the bulk drugs and formulations for which the respondent No.1 fixed ceiling price in accordance with paragraph 9 of DPCO 1995. For the present case, inclusion of ‘Theophylline’ in the First Schedule is relevant. The aforesaid DPCO 1995 consisted of 27 paragraphs, inter alia, providing for definitions of various terms used therein and also specified the powers of the respondent No.1 to fix retail price, ceiling price and to recover overcharged amounts from the entities in the business of manufacture and marketing of such bulk drugs and formulations.

3. The petitioner No.1 claims that it was exempted under a Notification dated 02.03.1995 issued by the respondent No.1, meant for small scale units. On 06.11.1995, the respondent No.1 issued Notification, fixing ceiling prices for various formulations of Theophylline. The petitioner No.1 was manufacturing Theophylline CR 300 mg tablets. Since the Notification issued by the respondent No.1, fixing ceiling prices for various formulations of Theophylline did not include Theophylline CR 300 mg tablets, the petitioner No.1 proceeded on the basis that there was no ceiling price. It is to be noted that certain variants of tablets were added by way of subsequent specific Notifications issued on 09.08.1996, but the aforesaid formulation of the petitioner No.1 was not included. Therefore, the petitioner No.1 proceeded on the basis that the ceiling price did not apply to the variant of Theophylline CR 300 mg tablet, as it was never notified by the respondent No.1.

4. After about 9 years, by issuing Notification dated 03.10.2006, the respondent No.1, for the first time, introduced ceiling prices for the variant Theophylline (CR/SR) 300 mg tablets. However, by this time, the petitioner No.1 had discontinued manufacturing its brand of Theophylline CR 300 mg tablet i.e. Phylobid CR 300 mg tablet.

5. Respondent No.1 claims that on 02.06.2008, it had issued a notice to the petitioner No.1 about alleged overcharging with regard to the said Phylobid CR 300 mg tablet i.e. brand name of the said petitioner for Theophylline CR 300 mg tablet. According to the petitioner No.1, it never received the said notice. We find that the documents placed on record by the respondent No.1 in this petition also do not support the assertion of the said respondent that the said notice was ever served upon the petitioner No.1.

6. There was no further action taken by the respondent No.1 and after about 9 years, on 18/20.02.2015, the respondent No.1 issued notice to the petitioner No.1, alleging that

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon Back to top